imiquimod has been researched along with Minimal Disease, Residual in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerestein, CG; Koeneman, MM; Kruse, AJ; van Beekhuizen, HJ; van de Sande, AJM; van Kemenade, FJ | 1 |
| Hsia, HC; Kim, S; Narayan, D; Norwich-Cavanaugh, A; Tsay, C | 1 |
| Apalla, Z; Argenziano, G; Evangelou, G; Ioannides, D; Kyrgidis, A; Lallas, A; Lazaridou, E; Lefaki, I; Patsatsi, A; Sidiropoulos, T; Sotiriou, E; Stratigos, A; Trakatelli, M; Tzellos, T; Zalaudek, I | 1 |
| Bontumasi, NM; Hurst, EA; Sheinbein, D | 1 |
| Biedrzycki, B; Chia, C; Garrett-Mayer, E; Gocke, C; Harding, TC; Hege, K; Jones, R; Kasamon, YL; Kowalski, J; Levitsky, HI; Miller, CB; Murphy, K; Qin, L; Smith, BD; Tsai, HL; Tu, GH | 1 |
| Guillén, C; Hilari, H; Llombart, B; Llorca, D; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillén, C; Traves, V; Villanueva, A | 1 |
| Spencer, JM | 1 |
| Breuninger, H; Caroli, UM; Eigentler, TK; Garbe, C; Kamin, A; Möhrle, M; Radny, P; Weide, BM | 1 |
| Goldberg, LH; Harting, M; Vujevich, J | 1 |
4 trial(s) available for imiquimod and Minimal Disease, Residual
| Article | Year |
|---|---|
TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
Topics: Adult; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Research Design; Single-Blind Method; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2018 |
K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate.
Topics: Adult; Aged; Aminoquinolines; Benzamides; Cancer Vaccines; Female; Fusion Proteins, bcr-abl; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Imatinib Mesylate; Imiquimod; Immunotherapy; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Neoplasm, Residual; Pilot Projects; Piperazines; Pyrimidines; Tumor Burden | 2010 |
Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Desiccation; Double-Blind Method; Electrosurgery; Female; Humans; Imiquimod; Male; Neoplasm, Residual; Pilot Projects; Skin Neoplasms; Treatment Outcome | 2006 |
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Administration Schedule; Emollients; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm, Residual; Skin Neoplasms; Treatment Outcome | 2007 |
5 other study(ies) available for imiquimod and Minimal Disease, Residual
| Article | Year |
|---|---|
An Algorithm for the Management of Residual Head and Neck Melanoma In Situ Using Topical Imiquimod: A Pilot Study.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents; Female; Head and Neck Neoplasms; Humans; Imiquimod; Male; Melanoma; Middle Aged; Neoplasm, Residual; Pilot Projects; Retrospective Studies; Skin Neoplasms | 2019 |
Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Dermoscopy; Humans; Imiquimod; Male; Middle Aged; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2014 |
Combination therapy for perianal squamous cell carcinoma in situ with imiquimod and photodynamic therapy.
Topics: Aminolevulinic Acid; Aminoquinolines; Anal Canal; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Dissection; Female; Humans; Imiquimod; Middle Aged; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Postoperative Complications; Skin Neoplasms; Treatment Outcome | 2014 |
Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual; Paraffin Embedding; Reoperation; Retrospective Studies; Skin Neoplasms; Skin Pigmentation; Treatment Outcome | 2012 |
Residual basal cell carcinoma after treatment with imiquimod: a caution on assuming complete cure.
Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Neoplasm, Residual; Scalp; Skin Neoplasms; Treatment Failure | 2007 |